| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1750-3639.2000.TB00262.X |
| P698 | PubMed publication ID | 10764048 |
| P2093 | author name string | Crocker SJ | |
| Nicholson DW | |||
| Robertson GS | |||
| Schulz JB | |||
| P2860 | cites work | A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing | Q22008514 |
| Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner | Q22008727 | ||
| The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy | Q24308680 | ||
| Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes | Q24315805 | ||
| X-linked IAP is a direct inhibitor of cell-death proteases | Q24318710 | ||
| The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases | Q24532851 | ||
| IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases | Q24533214 | ||
| The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis | Q27732868 | ||
| A combinatorial approach for determining protease specificities: application to interleukin-1beta converting enzyme (ICE) | Q27739379 | ||
| The CARD domain: a new apoptotic signalling motif | Q28239887 | ||
| A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD | Q28258328 | ||
| A single BIR domain of XIAP sufficient for inhibiting caspases | Q28266409 | ||
| Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis | Q28292299 | ||
| Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase | Q28302692 | ||
| Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus | Q28568186 | ||
| Identification and characterization of a spinal muscular atrophy-determining gene | Q29547495 | ||
| A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis | Q29617776 | ||
| Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9 | Q29618617 | ||
| Caspase structure, proteolytic substrates, and function during apoptotic cell death | Q33782479 | ||
| Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice | Q34408475 | ||
| Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis | Q34451533 | ||
| Prevention of apoptosis by a baculovirus gene during infection of insect cells | Q34993245 | ||
| Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage | Q36030783 | ||
| Control of programmed cell death by the baculovirus genes p35 and iap. | Q36662781 | ||
| Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. | Q36684306 | ||
| Constitutive expression of zif268 in neocortex is regulated by synaptic activity | Q37530737 | ||
| Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease | Q39116027 | ||
| Programmed cell death and the control of cell survival: lessons from the nervous system | Q40777905 | ||
| Non-specific effects of methyl ketone peptide inhibitors of caspases | Q40977161 | ||
| ITA, a vertebrate homologue of IAP that is expressed in T lymphocytes | Q41153607 | ||
| Fetal nigral transplantation as a therapy for Parkinson's disease | Q41367101 | ||
| Neurotrophic 3,9-bis[(alkylthio)methyl]-and-bis(alkoxymethyl)-K-252a derivatives | Q42439874 | ||
| Ischemia-induced CA1 neuronal death is preceded by elevated FosB and Jun expression and reduced NGFI-A and JunB levels. | Q42455690 | ||
| Adenovirus-mediated gene transfer of inhibitors of apoptosis protein delays apoptosis in cerebellar granule neurons. | Q42536897 | ||
| Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases | Q42657216 | ||
| Ischemic damage in the striatum of adult gerbils: relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons | Q45825152 | ||
| Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death | Q46725238 | ||
| Potassium deprivation-induced apoptosis of cerebellar granule neurons: cytochrome c release in the absence of altered expression of Bcl-2 family proteins. | Q47727128 | ||
| Staurosporine and K-252 compounds protect hippocampal neurons against amyloid beta-peptide toxicity and oxidative injury | Q48090525 | ||
| Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia. | Q48236502 | ||
| Caspase inhibition reduces apoptosis and increases survival of nigral transplants | Q48308615 | ||
| Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation | Q48373661 | ||
| Endonucleolytic DNA fragmentation is not required for apoptosis of cultured rat cerebellar granule neurons. | Q48465287 | ||
| Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. | Q48513221 | ||
| Bacterial alkaloids mitigate seizure-induced hippocampal damage and spatial memory deficits. | Q48912664 | ||
| Selective resistance of sensory cells of the mesencephalic trigeminal nucleus to kainic acid-induced lesions. | Q54568034 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 283-292 | |
| P577 | publication date | 2000-04-01 | |
| P1433 | published in | Brain Pathology | Q4955776 |
| P1476 | title | Neuroprotection by the inhibition of apoptosis | |
| P478 | volume | 10 |
| Q79211195 | (-)Clausenamide improves long-term potentiation impairment and attenuates apoptosis after transient middle cerebral artery occlusion in rats |
| Q44222357 | 17beta-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin |
| Q42120400 | 3-Aminopropanal, formed during cerebral ischaemia, is a potent lysosomotropic neurotoxin |
| Q40776107 | APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death. |
| Q48913487 | Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. |
| Q35844755 | Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage |
| Q33943954 | An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease |
| Q38726623 | Apoptosis Following Cortical Spreading Depression in Juvenile Rats. |
| Q34214558 | Apoptosis and its clinical impact |
| Q36262615 | Apoptosis and traumatic brain injury |
| Q43579106 | As originally published in 1994: dextrorphan inhibits the release of excitatory amino acids during spinal cord ischemia. Updated in 2001. |
| Q33953163 | BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia |
| Q30311030 | Basic science of closed head injuries and spinal cord injuries |
| Q38350224 | Bifunctional apoptosis inhibitor (BAR) protects neurons from diverse cell death pathways |
| Q73371207 | Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors |
| Q35049064 | Caspase inhibitors as anti-inflammatory and antiapoptotic agents. |
| Q36179653 | Caspase inhibitors as neuroprotective agents |
| Q44846933 | Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage |
| Q43570435 | Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice |
| Q40751610 | Caspase-mediated parkin cleavage in apoptotic cell death. |
| Q36430147 | Caspases at the crossroads of immune-cell life and death |
| Q43572884 | Cell-specific caspase expression by different neuronal phenotypes in transient retinal ischemia |
| Q43590657 | Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. |
| Q35184527 | Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro |
| Q50532094 | Changes in Oxidant Defense, Apoptosis, and Cognitive Abilities During Treatment for Childhood Leukemia. |
| Q48556024 | Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis. |
| Q36045223 | Clinical trials for cytoprotection in stroke |
| Q47230840 | Cloning of a novel Apaf-1-interacting protein: a potent suppressor of apoptosis and ischemic neuronal cell death. |
| Q42787289 | Comparison between axonal and retinal ganglion cell gene expression in various optic nerve injuries including glaucoma |
| Q35604975 | Cytotoxicity and Apoptosis Inducing Activities of 2-Amino-4H-chromene-3-carbonitrile Derivatives Loaded on Gold Nanoparticles Against Human Breast Cancer Cell Line T47D. |
| Q38944882 | DHT inhibits the Aβ25-35-induced apoptosis by regulation of seladin-1, survivin, XIAP, bax, and bcl-xl expression through a rapid PI3-K/Akt signaling in C6 glial cell lines |
| Q39860720 | Discovery of substituted N'-(2-oxoindolin-3-ylidene)benzohydrazides as new apoptosis inducers using a cell- and caspase-based HTS assay |
| Q28762978 | Dynamic role of postsynaptic caspase-3 and BIRC4 in zebra finch song-response habituation |
| Q47843506 | Effects of progesterone on the neonatal brain following hypoxia-ischemia |
| Q47447000 | Epoxyeicosatrienoic Acid Inhibits the Apoptosis of Cerebral Microvascular Smooth Muscle Cells by Oxygen Glucose Deprivation via Targeting the JNK/c-Jun and mTOR Signaling Pathways |
| Q55112446 | Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro |
| Q28569113 | Evidence for the involvement of Par-4 in ischemic neuron cell death |
| Q34099046 | Expression of cellular FLICE inhibitory proteins (cFLIP) in normal and traumatic murine and human cerebral cortex |
| Q34123876 | Functional human NAIP promoter transcription regulatory elements for the NAIP and PsiNAIP genes |
| Q33943273 | Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease |
| Q42502542 | Global ablation of the mitochondrial calcium uniporter increases glycolysis in cortical neurons subjected to energetic stressors |
| Q44345666 | In vitro hypoxia and excitotoxicity in human brain induce calcineurin-Bcl-2 interactions |
| Q36989579 | Increase in phosphorylation of Akt and its downstream signaling targets and suppression of apoptosis by simvastatin after traumatic brain injury |
| Q51074009 | Increased calpain expression is associated with apoptosis in rat spinal cord injury: calpain inhibitor provides neuroprotection. |
| Q46464188 | Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin-induced cell death |
| Q77122483 | Interferon-beta therapy downregulates the anti-apoptosis protein FLIP in T cells from patients with multiple sclerosis |
| Q52578189 | Introduction: Targeted modulation of neuronal apoptosis: a double-edged sword? |
| Q43777394 | Iodoacetate protects hippocampal neurons against excitotoxic and oxidative injury: involvement of heat-shock proteins and Bcl-2. |
| Q34624467 | Loss of caspase-2-dependent apoptosis induces autophagy after mitochondrial oxidative stress in primary cultures of young adult cortical neurons |
| Q35045715 | MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity |
| Q47576972 | Mice overexpressing human caspase 3 appear phenotypically normal but exhibit increased apoptosis and larger lesion volumes in response to transient focal cerebral ischaemia. |
| Q35134634 | Mitochondria in cell death: novel targets for neuroprotection and cardioprotection |
| Q34648892 | Mitochondrial involvement in the point of no return in neuronal apoptosis |
| Q35120756 | Mitochondrial potassium channels and uncoupling proteins in synaptic plasticity and neuronal cell death |
| Q34276988 | Mutations in apoptosis genes: a pathogenetic factor for human disease |
| Q35545552 | Neurogenic neuroprotection. |
| Q35886715 | Neuronal pathology in Parkinson's disease |
| Q34313475 | Neuroprotection for ischaemic stroke: an unattainable goal? |
| Q35036473 | Neuroprotective agents for the treatment of acute ischemic stroke |
| Q35182054 | Neuroprotective strategies in Parkinson's disease : an update on progress |
| Q34569654 | Pathophysiology, treatment, and animal and cellular models of human ischemic stroke |
| Q34137788 | Pharmacogenomics of neurodegenerative diseases |
| Q34340168 | Pharmacological treatment of traumatic brain injury: a review of agents in development |
| Q77110237 | Prevention of apoptotic neuronal death by controlling procaspases? A point of view |
| Q42704462 | Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson's disease |
| Q28216809 | Reduced expression of the inhibitor of apoptosis proteins in T cells from patients with multiple sclerosis following interferon-beta therapy |
| Q43850082 | Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult |
| Q40472194 | S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. |
| Q38989218 | Schiff bases in medicinal chemistry: a patent review (2010-2015). |
| Q59393051 | Selective inhibitors of apoptotic caspases: implications for novel therapeutic strategies |
| Q54996343 | Tamoxifen-induced knockdown of the mitochondrial calcium uniporter in Thy1-expressing neurons protects mice from hypoxic/ischemic brain injury. |
| Q35992142 | The anti-tumor effect of a polypeptide extracted from Tegillarca granosa Linnaeus on renal metastatic tumor OS-RC-2 cells |
| Q29547741 | The biochemistry of apoptosis |
| Q46968608 | The cytosolic loop of the gamma-secretase component presenilin enhancer 2 protects zebrafish embryos from apoptosis |
| Q37485957 | The mechanisms of brain ischemic insult and potential protective interventions |
| Q48174301 | The mechanisms of cell death in focal cerebral ischemia highlight neuroprotective perspectives by anti-caspase therapy. |
| Q28394257 | The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success |
| Q38706174 | Toxicity of Cisplatin-Loaded Poly Butyl Cyanoacrylate Nanoparticles in a Brain Cancer Cell Line: Anionic Polymerization Results |
| Q34361417 | Transcription factors in nerve regeneration |
| Q40671767 | Upregulation of the apoptosis regulators cFLIP, CD95 and CD95 ligand in peripheral blood mononuclear cells in relapsing-remitting multiple sclerosis |
| Q99609201 | Usnic acid improves memory impairment after cerebral ischemia/reperfusion injuries by anti-neuroinflammatory, anti-oxidant, and anti-apoptotic properties |
| Q35105106 | miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia |
Search more.